法定代表人：吴政杰 主管会计工作负责人：潘朝阳 会计机构负责人（会计主管人员）：潘朝阳 单位：万元 | 非经营性资金占用 | 资金占用方名称 | | 占用方与上市公 | 上市公司核算 | 2023 年期初占 | 2023 年 1-6 月占用累计 | 2023 年 1-6 月占用 | 2023 年 1-6 月偿 | 2023 年 6 月末 | 占用形成原 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 司的关联关系 | 的会计科目 | 用资金余额 | 发生金额（不含利息） | 资金的利息(如有) | 还累计发生金额 | 占用资金余额 | 因 | | | 控股股东、实际控制人及 | | | | | | | | | | | 非经营性占用 | | 其附属企业 | | | | | | | | | | | 非经营性占用 | | 小计 | | - | - | - | | | | | | - | - | | 前控股股东、实际控制人 | | | | | | | | | | | 非经营性占用 | ...

证券代码：301065 证券简称：本立科技 公告编号：2023-026 浙江本立科技股份有限公司 关于召开公司 2023 年第一次临时股东大会通知的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 一、召开会议的基本情况 1、股东大会届次：2023 年第一次临时股东大会 2、召集人：公司董事会 3、会议召开的合法、合规性： （1）公司第三届董事会第十二次会议于 2023 年 8 月 25 日召开，审议通过 了《关于召开公司 2023 年第一次临时股东大会的议案》。 （2）本次股东大会的召集、召开符合有关法律、行政法规、部门规章、规 范性文件和《公司章程》等相关规定。 4、会议召开的日期、时间： （1）现场会议召开时间：2023 年 9 月 15 日（星期五）14:30。 7、会议出席对象： （1）截至 2022 年 9 月 12 日（星期二）下午收市时，在中国证券登记结算 有限责任公司深圳分公司登记在册的公司全体已发行有表决权股份的股东均有 权出席本次股东大会，并可以以书面形式委托代理人出席会议和参加表决，该代 理人不必是本公司股东； （2）公司董事、监事 ...

证券代码：301065 证券简称：本立科技 公告编号：2023-023 经与会董事认真审议，形成以下决议： （一）审议通过了《关于<2023 年半年度报告>及其摘要的议案》 经审议，董事会认为：公司《2023 年半年度报告》及其摘要内容真实、 准确、完整地反映了公司 2023 年半年度财务状况和经营情况，不存在虚假 记载、误导性陈述或重大遗漏。 具体内容详见公司于同日披露在巨潮资讯网（http://www.cninfo.co m.cn）上的《2023 年半年度报告》和《2023 年半年度报告摘要》。 浙江本立科技股份有限公司 第三届董事会第十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 浙江本立科技股份有限公司（以下简称"公司"）第三届董事会第十 二次会议于 2023 年 8 月 25 日在公司三楼会议室以现场结合通讯的方式召 开。本次会议通知已于 2023 年 8 月 15 日以邮件方式向公司全体董事发出。 本次会议由公司董事长吴政杰先生主持,会议应到董事 7 人，实到董事 7 人，公司监事、高级管理人员列席会议。 ...

二、募集资金投资项目情况 根据公司《首次公开发行股票并在创业板上市招股说明书》及公司于2022 年3月29日召开第三届董事会第六次会议、第三届监事会第五次会议以及2022 年4月15日召开的2022年第一次临时股东大会，审议通过了《关于部分募投项 目实施方式变更和投资总额调整的议案》、《关于部分募投项目实施主体和实施 一、募集资金基本情况 经中国证券监督管理委员会《关于同意浙江本立科技股份有限公司首次公 开发行股票注册的批复》（证监许可[2021]2601号）同意，公司获准向社会公开 发行人民币普通股（A股）股票17,680,000股，每股面值1元，每股发行价格为 人民币42.50元，募集资金总额为人民币751,400,000.00元，扣除发行费用总额 68,144,762.18元（不含增值税）后，实际募集资金净额为683,255,237.82元。 立信会计师事务所（特殊普通合伙）已于2021年9月8日对首次公开发行股票的 资金到位情况进行了审验，并出具《浙江本立科技股份有限公司验资报告》（信 会师报字[2021]第ZF10873号）。公司对募集资金采取专户存储制度，并与保荐 机构、存放募集资金的商业银行签署 ...

浙江本立科技股份有限公司 根据《上市公司监管指引第 8 号——上市公司资金往来、对外担保的监管 要求》、《深圳证券交易所上市公司自律监管指引第 2 号--创业板上市公司规 范运作》及《公司章程》、《独立董事工作细则》等有关规定的要求，作为公 司独立董事，我们对公司控股股东及其他关联方占用公司资金、公司对外担保 的情况进行了认真的核查，发表专项说明及独立意见如下： 1、报告期内，公司不存在控股股东及其他关联方违规占用公司资金的情 况，亦不存在以前年度发生并延续至 2023 年半年度的控股股东及其他关联方 占用公司资金的情况，公司与控股股东及其他关联方的资金往来能够严格遵守 浙江本立科技股份有限公司 《上市公司监管指引第 8 号——上市公司资金往来、对外担保的监管要求》的 规定，不存在与相关法律、法规、规定相违背的情形。 2、报告期内，公司不存在为股东、股东的控股子公司、股东的附属企业 及其他关联方、任何非法人单位或个人提供担保的情况。报告期内，公司没有 提供过任何对外担保，也不存在以前年度发生并累计至 2023 年 6 月 30 日的对 外担保情形。 浙江本立科技股份有限公司 独立董事关于第三届董事会第十二次会 ...

编号：2023-001 | 投资者关系活动类别 | ☐特定对象调研 ☐分析师会议 | | --- | --- | | | ☐媒体采访 业绩说明会 | | | ☐新闻发布会 ☐路演活动 | | | ☐现场参观 | | | ☐其他（请文字说明其他活动内容） | | 参与单位名称及人员姓名 | 线上参与公司2022年度业绩说明会的全体投资者 | | 时间 | 2023年05月19日 15:00-17:00 | | 地点 | 价值在线（https://www.ir-online.cn/）网络互动 | | | 董事长兼总经理 吴政杰 | | | 独立董事 陈六一 | | 上市公司接待人员姓名 | 副总经理兼财务负责人 潘朝阳 | | | 副总经理兼董事会秘书 王佳佳 | | | 保荐代表人 刘逢敏 1.贵公司有意向光刻胶产业项目？打算什么时候投产。 | | | 答:公司现有产品及在建项目暂无光刻胶相关产品。 | | 投资者关系活动主要内容 | 2.在哪观看？ | | 介绍 | 答：投资者可于2023年05月19日（星期五）15:00-17:00通过网 | | | 址https://eseb.cn/14ARLnCF2L ...

证券代码：301065 证券简称：本立科技 公告编号：2023-014 浙江本立科技股份有限公司 关于举办2022年度网上业绩说明会的公告 （www.ir-online.cn）举办 2022 年度网上业绩说明会，与投资者进行沟通和交 流，广泛听取投资者的意见和建议。 一、说明会召开的时间、地点和方式 会议召开时间：2023 年 05 月 19 日（星期五）15:00-17:00 会议召开地点：价值在线（www.ir-online.cn） 会议召开方式：网络互动方式 二、参加人员 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示： 浙江本立科技股份有限公司（以下简称"公司"）已于 2023 年 4 月 27 日在 巨潮资讯网（http://www.cninfo.com.cn）上披露了《2022 年年度报告全文》及《2022 年年度报告摘要》。为便于广大投资者更加全面深入地了解公司经营业绩、发展 战略等情况，公司定于 2023 年 05 月 19 日（星期五）15:00-17:00 在"价值在线" 会议召开时间：2023 年 05 月 19 日（星期五 ...

Financial Performance - The company reported a total revenue of 350 million in 2022, representing a year-on-year increase of 49.2%[140]. - The company's operating revenue for 2022 was ¥758,739,325.03, representing a 22.16% increase compared to ¥621,104,645.37 in 2021[20]. - The net profit attributable to shareholders for 2022 was ¥59,489,850.35, an increase of 8.51% from ¥54,824,924.50 in 2021[20]. - Total revenue for 2022 reached ¥758.74 million, a year-on-year increase of 22.16% compared to ¥621.10 million in 2021[64]. - The pharmaceutical intermediates segment generated ¥694.89 million, accounting for 91.59% of total revenue, with a year-on-year growth of 14.51%[64]. - The pesticide intermediates segment saw a significant increase in revenue to ¥40.37 million, up 182.75% from ¥14.28 million in 2021[64]. - The company reported a gross margin of 12.81% for pharmaceutical intermediates, down 3.72% from the previous year[67]. - The company reported a significant focus on research and development for new products, particularly in the pharmaceutical and chemical intermediate sectors[15]. Dividend and Shareholder Information - The company plans to distribute a cash dividend of 1.5 RMB per 10 shares to all shareholders, based on a total of 70,680,000 shares[3]. - The total distributable profit for the year is reported at 373,257,062.38 RMB, with the cash dividend representing 100% of the profit distribution[169]. - The company will also increase its capital stock by 5 shares for every 10 shares held, resulting in a total increase of 35,340,000 shares, bringing the total share count to 106,020,000[171]. Research and Development - The company invested 26.92 million yuan in R&D, accounting for 3.55% of operating revenue, and holds 24 invention patents, 6 utility model patents, and 6 software copyrights[58]. - Research and development (R&D) expenses increased by 35.54% to ¥26,921,324.12, driven by higher personnel costs and external development fees[76]. - The number of R&D personnel increased by 7.27% to 59, with a notable rise in the number of master's degree holders by 25%[78]. - The company aims to continue increasing R&D investment to enhance new product development and industrialization efficiency, aiming to enrich its product variety and improve core competitiveness[107]. Market Strategy and Expansion - The company aims to expand its market presence and enhance its competitive edge through strategic mergers and acquisitions[15]. - The company is actively pursuing mergers and acquisitions to enhance its market position and technological capabilities[96]. - The company plans to expand existing product capacity and enter the raw material and fragrance sectors to optimize the industrial chain and reduce operational risks[108]. - The sales strategy includes a focus on domestic markets while also exploring international opportunities through trade partnerships[40]. Production and Operational Efficiency - The production model is driven by customer orders and market forecasts, ensuring flexibility in production planning to meet sales fluctuations[38]. - The company has adopted lean management practices to improve production efficiency and product quality, achieving significant enhancements in operational performance over the past year[60]. - The company has strengthened internal management and optimized business processes, enhancing operational efficiency and risk control through transparent management practices[61]. - The company plans to enhance production efficiency through technological upgrades to existing production lines for 801 products[98]. Environmental and Safety Management - The company is committed to safety and environmental management throughout its production processes, ensuring compliance with regulations and enhancing employee safety awareness[39]. - The company has implemented a comprehensive EHS management system, increasing safety and environmental management levels, and was awarded the title of Zhejiang Province Water-Saving Benchmark Enterprise[59]. - The company has actively engaged in energy-saving and emission-reduction initiatives, contributing to improved production efficiency and reduced pollution emissions[186]. - The company emphasizes a clean production approach and has made efforts to improve employee environmental awareness and supervision[182]. Corporate Governance and Management - The company has established a comprehensive internal audit system to enhance board decision-making and ensure effective supervision of management, with a focus on the authenticity and completeness of financial information[124]. - The company maintains independence in assets, personnel, finance, organization, and business operations, ensuring no interference from controlling shareholders[127][129][130][131][132][133]. - The board held a total of 4 meetings during the reporting period, with significant resolutions passed regarding financial reports and internal audits[159]. - The company emphasizes information disclosure and aims to enhance transparency and timeliness in reporting to investors[112]. Employee Management and Development - The total number of employees at the end of the reporting period was 428, with 417 in the parent company and 11 in major subsidiaries[163]. - The company has established a performance-based salary system, including annual salary for middle and senior management, performance-based pay for technical staff, and piece-rate pay for production workers[165]. - The company aims to enhance employee compensation annually based on business performance and labor market conditions to ensure competitive advantages in salary[165]. - The company has implemented a comprehensive training program focusing on various skill sets and management capabilities to support rapid development[166]. Investment and Financial Management - The company reported a net decrease in cash and cash equivalents of ¥119,400,325.75, a significant decline compared to the previous year[80]. - The company has committed to a new project with a total investment of 5,000 million, which is fully allocated for operational funding[96]. - The company has established long-term stable relationships with major clients, enhancing product quality control and customer service levels to promote product quality upgrades and diversification[53]. - The company has a structured remuneration system based on position, years of service, and performance evaluations for its directors and senior management[151].

Financial Performance - The company's revenue for Q1 2023 was ¥170,479,038, a decrease of 14.56% compared to ¥199,539,234 in the same period last year[5]. - Net profit attributable to shareholders was ¥12,394,500, down 21.87% from ¥15,863,012 in Q1 2022[5]. - Total operating revenue for the current period is ¥170,479,038, a decrease of 14.6% from ¥199,539,234 in the previous period[20]. - Net profit for the current period is ¥12,394,500.46, a decline of 21.6% compared to ¥15,863,012.65 in the previous period[21]. - The company reported a total profit of ¥13,710,136.23, down from ¥17,933,569.31 in the previous period[21]. - Basic and diluted earnings per share are both ¥0.18, compared to ¥0.22 in the previous period[21]. Cash Flow and Investments - The net cash flow from operating activities decreased by 76.95%, amounting to ¥4,831,414.87 compared to ¥20,964,247.56 in the previous year[10]. - The company experienced a 105.01% increase in cash outflow from investing activities, amounting to -¥13,887,070.18 due to higher fixed asset investments[10]. - Operating cash flow net amount is ¥4,831,414.87, significantly down from ¥20,964,247.56 in the previous period[23]. - Cash and cash equivalents at the end of the period were CNY 544,003,174.24, slightly down from CNY 553,058,829.55[17]. - Cash and cash equivalents at the end of the period are ¥544,003,174.24, down from ¥679,032,171.26 at the end of the previous period[24]. Assets and Liabilities - Total assets increased by 1.86% to ¥1,420,386,494.43 from ¥1,394,430,627.65 at the end of the previous year[5]. - Current assets totaled CNY 814,424,221.20, up from CNY 788,373,543.53, indicating an increase of about 3.67%[17]. - Total liabilities increased to CNY 161,084,374.30 from CNY 147,523,007.98, marking an increase of approximately 9.67%[18]. - The total equity attributable to shareholders of the parent company reached CNY 1,259,302,120.13, up from CNY 1,246,907,619.67, reflecting a growth of about 0.41%[19]. Receivables and Prepayments - Accounts receivable rose by 26.90% to ¥66,867,826.33, primarily due to a higher amount of receivables still within the credit period[8]. - Accounts receivable rose to CNY 66,867,826.33 from CNY 52,694,889.30, representing a significant increase of approximately 26.87%[17]. - Prepayments surged by 317.71% to ¥6,893,818.98, mainly due to increased advance payments for raw materials[8]. - The company reported a significant increase in prepayments, which rose to CNY 6,893,818.98 from CNY 1,650,372.13, an increase of approximately 318.66%[17]. Operating Costs and Expenses - Total operating costs decreased to ¥156,987,177.98, down 13.8% from ¥182,199,147.28 in the previous period[20]. - Research and development expenses increased to ¥5,829,707.18, up from ¥5,079,329.93 in the previous period[20]. - Sales expenses decreased to ¥168,387.89 from ¥214,091.43 in the previous period[20]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,546[11]. - The report indicates no changes in the number of preferred shareholders and limited changes in restricted shares, suggesting stability in shareholder structure[14]. Other Observations - The company reported a significant increase in tax and additional fees by 187.75%, totaling ¥1,528,267.50 compared to ¥531,108.21 in the previous year[9]. - The weighted average return on equity decreased to 0.99% from 1.30% year-on-year[5]. - The company's short-term borrowings and other financial liabilities were not detailed in the provided data, indicating a focus on operational liquidity management[18]. - The company has not reported any new product developments or market expansions in this quarter[25].

Financial Performance - The company's revenue for Q3 2022 reached ¥172,277,422.57, representing a 15.85% increase compared to the same period last year, and a total revenue of ¥597,167,430.98 for the year-to-date, up 24.99%[5] - Net profit attributable to shareholders for Q3 2022 was ¥10,240,205.46, a slight increase of 0.25% year-on-year, while the year-to-date net profit reached ¥51,763,132.22, up 13.54%[5] - Total operating revenue for Q3 2022 reached ¥597,167,430.98, an increase of 25.0% compared to ¥477,774,804.52 in Q3 2021[21] - Operating profit for the period was ¥57,642,155.34, up from ¥50,205,198.49 in the same period last year, reflecting a growth of 4.3%[22] - Net profit attributable to shareholders of the parent company was ¥51,763,132.22, representing a 13.5% increase from ¥45,590,862.44 in Q3 2021[22] Earnings and Shares - The basic earnings per share for Q3 2022 decreased by 26.32% to ¥0.14, with a year-to-date figure of ¥0.73, down 15.12%[5] - The basic earnings per share for Q3 2022 was ¥0.73, down from ¥0.86 in the previous year, reflecting a decrease of 15.1%[22] - The total number of common shareholders at the end of the reporting period is 10,601[13] - The largest shareholder, Wu Zhengjie, holds 24.18% of the shares, totaling 17,090,000 shares[13] - The total number of restricted shares at the end of the period is 40,387,500, with 13,300,000 shares released from restrictions during the period[14] Assets and Liabilities - The total assets as of September 30, 2022, amounted to ¥1,380,010,918.80, reflecting a 1.74% increase from the end of the previous year[5] - Total assets increased to ¥1,380,010,918.80, compared to ¥1,356,444,633.92 at the end of Q3 2021, marking a growth of 1.7%[20] - Total liabilities decreased to ¥141,434,367.26 from ¥144,893,214.60, a reduction of 2.5% year-over-year[20] - The company's total equity attributable to shareholders increased by 2.23% to ¥1,238,576,551.54 compared to the end of the previous year[5] Cash Flow - The cash flow from operating activities for the year-to-date was ¥13,978,347.65, showing a significant decline of 50.06% compared to the previous year[10] - The net cash flow from operating activities for the current period is ¥13,978,347.65, a decrease of 50.1% compared to ¥27,988,252.54 in the previous period[23] - Cash inflow from operating activities totaled ¥292,899,757.61, up 76.2% from ¥166,045,852.20 in the previous period[23] - Cash outflow from operating activities increased to ¥278,921,409.96, compared to ¥138,057,599.66 in the previous period, representing a 102.5% increase[23] - The net cash flow from investing activities is -¥107,189,528.51, which is a 93.5% increase in outflow compared to -¥55,274,028.84 in the previous period[24] - The net cash flow from financing activities is -¥25,004,964.89, a significant decrease from a net inflow of ¥658,554,260.13 in the previous period[24] - The total cash and cash equivalents at the end of the period is ¥546,639,544.90, down from ¥674,648,697.36 at the end of the previous period[24] - The company received cash from investment totaling ¥726,016,000.00 during the financing activities[24] - The company paid out ¥24,776,164.64 in dividends and interest during the financing activities, compared to ¥1,629,664.40 in the previous period[24] Research and Development - The company reported a 43.58% increase in R&D expenses, totaling ¥18,273,424.74 for the year-to-date, attributed to rising personnel costs and external development fees[9] - Research and development expenses rose to ¥18,273,424.74, up 43.7% from ¥12,727,267.98 in Q3 2021, indicating a focus on innovation[21] - The company has ongoing research and development efforts, although specific new products or technologies were not detailed in the provided content[16] Investments and Acquisitions - The net cash flow from investment activities was negative at -¥107,189,528.51, a 93.92% increase in outflows due to the acquisition of land use rights by a wholly-owned subsidiary[12] - The company acquired land use rights for ¥92.4 million for a specific plot of land[15] - The company is exploring market expansion opportunities, as indicated by its acquisition of land for development purposes[15] Other Financial Metrics - The company received government subsidies amounting to ¥1,962,457.55 in Q3 2022, contributing to a total of ¥6,019,203.52 for the year-to-date[7] - The company's cash and cash equivalents decreased from ¥664,855,690.65 at the beginning of the year to ¥546,639,544.90 by September 30, 2022, a decline of approximately 17.7%[18] - Accounts receivable increased from ¥47,987,148.55 to ¥54,797,718.61, representing an increase of about 14.9%[18] - The total current assets decreased from ¥872,928,045.58 to ¥795,627,204.96, a reduction of approximately 8.9%[18] - Deferred tax assets remained stable at ¥5,726,232.72, slightly down from ¥5,740,991.53 in Q3 2021[20] - The company reported a financial expense of -¥12,608,809.02, a significant improvement compared to ¥964,458.92 in Q3 2021, indicating better financial management[21] - The company reported a significant increase in cash received from other operating activities, totaling ¥19,364,603.23, compared to ¥6,067,787.92 in the previous period[23]